A systematic review and meta-analysis of studies have revealed that pre-existing conditions may increase a COVID-19 patient's risk of death by one-and-a-half to three times
This standard 96-well ELISA based assay is a game changer for evaluating convalescent plasma, antibody therapies and determining the effectiveness of vaccines for COVID-19
A crucial part of the global effort to stem the spread of the pandemic is the development of tests that can rapidly identify infections in asymptomatic people